Japanese
English
Access
Contact
Site Map
What are iPS cells?
For patients and their families
For patients
For researchers and companies
For researchers
Make a Gift
RSS
Research
Phase I clinical trial of bosutinib for amyotrophic lateral sclerosis (ALS); iDReAM study
A new sensitive method to detect for minute amounts of contaminating undifferentiated iPS cells
Immunosuppressive regimens after a heart transplant can hamper good therapeutic progressions in fibrosis
A novel method for generating naive human iPS cells with significantly higher differentiation potency
Successful generation of human iPS cell-derived mesenchymal cells capable of producing alveolar organoids
An important host factor in SARS-CoV-2 infection, identified using iPS cell and organoid technology
Others
CiRA Reporter Vol.32 is available now
A study using an organ-on-a-chip reveals a mechanism of SARS-CoV-2 invasion into blood vessels ~Disruption of vascular endothelial barrier in respiratory organs by decreasing Claudin-5 expression~
